Back to search

Article

A randomized double-blind placebo-controlled clinical trial of Guanfacine Extended Release for aggression and self-injurious behavior associated with Prader-Willi Syndrome

2024-08-22

Abstract excerpt

<h4>Introduction: </h4> Prader-Willi Syndrome (PWS), a rare genetic disorder, affects development and behavior, frequently resulting in self-injury, aggression, hyperphagia, oppositional behavior, impulsivity and over-activity causing significant morbidity. Currently, limited therapeutic options are available to manage these neuropsychiatric manifestations. The aim of this clinical trial was to assess the efficacy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e51f5202-7fef-56a0-bed3-45ab405bc911
DOI
10.1101/2024.08.22.24312419
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A randomized double-blind placebo-controlled clinical trial of Guanfacine Extended Release for aggression and self-injurious behavior associated with Prader-Willi SyndromeDOI 10.1101/2024.08.22.24312419
Select a neighboring publication to make it the new centre.